The notices it replaced
Its page was not saved, so the notices it replaced are not known.
Who won it before
4 competing awards (new and renewals) from FY2014 to FY2025 under this notice and the notices it replaced: $3,053,037 in first-year total cost, median $757,479.
Most frequent study sections
- Special Emphasis Panel[ZDK1 GRB-S (O2)]4
Most frequent institutions
- BROAD INSTITUTE, INC.1
- OREGON HEALTH & SCIENCE UNIVERSITY1
- STANFORD UNIVERSITY1
- UNIVERSITY OF CALIFORNIA, SAN FRANCISCO1
| FY | Project | PIs | Institution | First-year cost | Study section |
|---|---|---|---|---|---|
| 2019 | One-compound, one-islet: A high-throughput platform for small-molecule discovery1U01DK123717-01 | CHOUDHARY, AMITKULKARNI, ROHIT N.WAGNER, BRIDGET K | BROAD INSTITUTE, INC., MA | $794,208 | ZDK1 |
| 2019 | Therapeutic targeting of human islets with recombinant regulatory T cells1U01DK123743-01 | KIM, SEUNG KMEYER, EVERETTPOWERS, ALVIN C | STANFORD UNIVERSITY, CA | $762,962 | ZDK1 |
| 2019 | Partial Antagonists of IRE1 RNase—‘PAIR’s—to treat Type 1 Diabetes1U01DK123609-01 | MALY, DUSTIN JPAPA, FEROZ R | UNIVERSITY OF CALIFORNIA, SAN FRANCISCO, CA | $751,996 | ZDK1 |
| 2019 | Gene Therapy for Diabetes1U01DK123608-01 | GROMPE, MARKUSKAY, MARK ANAKAI, HIROYUKI | OREGON HEALTH & SCIENCE UNIVERSITY, OR | $743,871 | ZDK1 |
Data: Grants.gov's daily extract and NIH's notice pages and award files, in ScienceGraph release conductgrants-2026-11-10-0.1.1. An award is listed only where NIH's own record names the notice, and a PI only by NIH's profile ID. Grants.gov and NIH do not endorse ScienceDex.